Home/Filings/4/0001725160-24-000163
4//SEC Filing

Vultaggio Vincent 4

Accession 0001725160-24-000163

CIK 0001725160other

Filed

Oct 3, 8:00 PM ET

Accepted

Oct 4, 6:01 PM ET

Size

5.2 KB

Accession

0001725160-24-000163

Insider Transaction Report

Form 4
Period: 2024-10-04
Transactions
  • Sale

    Common Stock

    2024-10-04$3.18/sh1,603$5,09833,855 total
Footnotes (1)
  • [F1]A portion of the shares were sold automatically to satisfy withholding tax obligations upon the vesting of restricted stock units, and the remainder of the shares were sold pursuant to a Rule 10b5-1 instruction adopted by the Reporting Person on September 20, 2023.

Issuer

Zentalis Pharmaceuticals, Inc.

CIK 0001725160

Entity typeother

Related Parties

1
  • filerCIK 0002018766

Filing Metadata

Form type
4
Filed
Oct 3, 8:00 PM ET
Accepted
Oct 4, 6:01 PM ET
Size
5.2 KB